Cronos Group Inc. has grown revenue 24% a year over three years and 26% a year over five. Revenue growth, 3-year annual rate: +24% (Drug Manufacturers - Specialty & Generic median +15%). Revenue growth, 5-year rate: +26%, growth has slowed since the five-year average. Years of annual history on file: 9, FY2017 to FY2025, as filed.

CRONCronos Group Inc.

HealthcareUSD

$3.55

$2.3052 weeks$3.55

Is it growing?

Is CRON growing?

Cronos Group Inc. has grown revenue 24% a year over three years and 26% a year over five.

+24%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +15% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +26%
Revenue growth, 5-year rate · +24% over three · growth has slowed since the five-year average
Years of annual history on file: 9
Years of annual history on file · FY2017 to FY2025, as filed

Details›